CTRI/2022/01/039786尚未招募2 期
To evaluate the effectiveness of oral pentoxifylline in moderate COVID â?? 19
Dr Subhash Gupta0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult male or female patients, with proven COVID-19 moderate disease with any one of respiratory rate 24- 30/min, breathlessness, SPO2 90-93% on room air will be included in the study.
排除标准
- •(a)Children < 18 years of age, age >70 years
- •(b)Pregnancy & lactation
- •(c)History of GI bleeding
- •(d)History of Seizures, Cardiac or other vascular stents
- •(e)History of intracranial hemorrhage
- •(f)Patients with recent cerebral and/or retinal hemorrhage/ intracranial haemorrhage
- •(g)Pts with serum ALT/AST > 5 times the upper limit of normal
- •(h)In patients who have previously exhibited intolerance to this product
研究者
相似试验
已完成
2 期
Effectiveness of pentoxifylline in contrast induced nephropathyRenal failureContrast Nephropathy.N17, N18,IRCT2015102624713N1Vice chancellor for research,Zahedan University of Medical Sciences60
已完成
3 期
Investigation of the effect of pentoxifylline on the prevention of radio contrast nephropathyIRCT20161219031464N4Shahid Beheshti University of Medical Sciences192
招募中
2 期
Effect of pentoxifylline in treatment of patients with slow flow coronary arteriesIRCT20210711051842N1Mashhad University of Medical Sciences40
尚未招募
2 期
Assessing the Impact of Oral Pentoxifylline and Vitamin E on Oral Submucous FibrosisCTRI/2024/04/066118Government College of Dentistry
已完成
4 期
Eeffective of pentoxifyllin on recurrence endometriosisEndometriosis of uterus.Endometriosis of uterusIRCT201109087513N1Isfahan University of Medical Sciences-Research Council83